1.Regulation of energy metabolism in colon cancer cells by chidamide
Mu HE ; Zhixin QIAO ; Suping REN ; Changlan LI ; Yanbing WANG ; Qiyuan GUI ; Yu WANG ; Yunjing LUO ; Qun YU
Chinese Journal of Pharmacology and Toxicology 2016;30(5):539-544
OBJECTIVE To observe the regulation effect of chidamide on energy metabolism in HCT-8 and HT-29 cells. METHODS HCT-8 and HT-29 cells were treated with chidamide 5,10 and 20 μmol · L-1. Morphological changes of these cells were observed under an ordinary optical microscope. Cell proliferation was detected by MTT. ATP production was determined by CellTiter-Glo? assay kit. Metabolic changes were tested by glycolytic stress kit. The mRNA level of lactate dehydrogenase A (LDH-A)was analyzed by real-time quantitative PCR,whereas the protein level of LDH-A was analyzed by Western blotting. RESULTS Compared with control group,cell morphology of HCT-8 and HT-29 cells in chidamide treated group was irregular,accompanied by deformation,shrinkage and cell debris, and the inhibitory rate of proliferation increased(P<0.05). There was no significant difference in ATP total content between chidamide 5 and 10 μmol · L-1 16 h treatment groups,but in chidamide 20 μmol · L-1 treatment group it was decreased(P<0.05). Chidamide 20μmol · L-1 had no effect on oxygen consumption rate, but glycolysis ATP generation rate was reduced by 30.7% and 37.9%(P<0.05),respectively. Chidamide 20μmol · L-1 had no effect on LDH-A mRNA level,but it decreased the protein level of LDH-A(P<0.01). CONCLUSION Chidamide can abate the respiratory metabolic ability of HCT-8 and HT-29 cells. The mechanism may be related to the down-regulation of LDH-A.
2.Progress of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in children
International Journal of Pediatrics 2023;50(9):595-599
In pediatric patients undergoing allogeneic hematopoietic stem cell transplantation(allo-HSCT), the incidence of autoimmune hemolytic anemia(AIHA)ranges from 2% to 6%.Risk factors include younger age at transplantation, non-malignant diseases, unrelated donor transplant, use of lymphocyte-depleting agents, and chronic graft-versus-host disease.These risk factors share the common characteristic of incomplete immune reconstitution or immune dysregulation post-HSCT, which may be related to the pathogenesis of AIHA.The treatment of post-transplant AIHA is challenging, with no standardized treatment guidelines currently available.Steroids remain the first-line treatment, but the relapse rate is high, with a complete remission rate of approximately 30%.Other conventional treatments such as intravenous immunoglobulin, plasma exchange, and splenectomy are usually ineffective for post-transplant AIHA.In recent years, some studies have explored second or third-line treatment options using monoclonal antibodies and immunosuppressive agents, with higher remission rates.However, the limited availability of studies makes sustained remission uncertain.This article reviews the progress in risk factors, pathogenesis, diagnosis and therapeutic options for post-transplant AIHA, providing improved strategies for the treatment of refractory/recurrent AIHA.
3.Spatial distribution characteristics of severe fever with thrombocytopenia syndrome in Yantai City of Shandong Province from 2015 to 2020
Changlan YU ; Lifang XU ; Xiuwei LIU ; Jingyu LIU ; Shuting HOU ; Tao LIU
Chinese Journal of Endemiology 2022;41(7):540-545
Objective:To analyze the spatial distribution characteristics and spatial aggregation of the epidemic of severe fever with thrombocytopenia syndrome(SFTS) in Yantai City of Shandong Province, and to provide basis for formulating effective SFTS prevention and control measures.Methods:The epidemic data of SFTS confirmed cases in each township (street) in Yantai City, Shandong Province from 2015 to 2020 were collected from the "China Disease Prevention and Control Information System Infectious Disease Monitoring and Reporting System", and ArcGIS 10.2 software was used for spatial autocorrelation analysis.Results:From 2015 to 2020, a total of 839 SFTS cases were reported in Yantai City, including 124 deaths; with an average annual incidence rate of 2.14/100 000, and a total case fatality rate of 14.78%. Global spatial autocorrelation analysis showed that the distribution of SFTS cases in Yantai City from 2015 to 2020 showed a positive spatial correlation, with the highest spatial correlation in 2015 (Moran's I = 0.25, Z = 5.66, P < 0.001), and the lowest in 2018 (Moran's I = 0.16, Z = 3.69, P < 0.001). Local spatial autocorrelation and hotspot analysis showed that the epidemic areas of SFTS were mainly in some mountainous and hilly townships (streets) of Laizhou City, Penglai District, Qixia City, Zhaoyuan City, and Haiyang City. Conclusions:The distribution of SFTS epidemic in Yantai City has obvious regional clustering. Intervention measures such as publicity, education and monitoring should be strengthened in high-incidence areas to reduce the incidence of the disease.